Does anyone know what the proper conversion is between Phred quality scores and the probability values required by the RMAP alignment software? RMAP's documentation doesn't have much to say on the matter.
Unconfigured Ad
Collapse
X
-
Tags: None
-
I think I've answered my own question...
RMAP seems to be pretty fussy about the prb file format. The four probabilities at each base are given as Solexa/Phred qualities (e.g: 40 -40 -40 -40). They seem to use spaces to separate the four probabilities and tabs to separate the blocks of probabilities for each base. I don't know how necessary that is but I didn't mess with it. RMAP does seem to be sensitive to the end of the line. There cannot be whitespace at the end of the line except for the newline. Each line represents a single read, so you have 4 x readLength numbers on each line and there are no labels so they have to be in the exact same order as your corresponding FASTA file of sequences.
Of course, FASTQ quality strings only give the probability that the called base is correct. To make pseudo-probabilities for the other three bases, I have been subtracting the FASTQ probability from 1, dividing by three, and converting back into a Phred quality.
I have a script working to do the conversion in case anyone is interested.
I wish that RMAP would support FASTQ files as an option... our core facility is currently throwing out the prb files.Last edited by ShaunMahony; 05-09-2008, 12:16 PM.
-
at least some core facility support dont understand the value of the prb files ... after thinking about doing what you did, i decided it didnt make sense to try to reverse-engineer the prb scores ... note that for equivalent probabilities, the fastq file will simply select the first (!?) ... if you run the script on a fastq file that you actually have the prb file and learn something, it would be interesting to know how much "better" rmapq with the prb file does over just rmap with the fasta file ...
i think?
rudy
Comment
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 07:41 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
Comment